Skip to main content
Top
Published in: Clinical Autonomic Research 4/2013

Open Access 01-08-2013 | Research Article

Gravimetry in sweating assessment in primary hyperhidrosis and healthy individuals

Authors: Tomasz J. Stefaniak, Monika Proczko

Published in: Clinical Autonomic Research | Issue 4/2013

Login to get access

Abstract

Objective

Though hyperhidrosis is generally considered a subjectively perceived disease, it seems more and more doubtful that merely subjective evaluation is sufficient to qualify the patient to surgery. The aim of this study was to develop further gravimetry as a method of evaluation of sweating intensity and determination of the applicability of it in post-operative follow-up of primary hyperhidrosis (PHH) patients.

Methods

Total of 1,485 gravimetry assays has been performed in 343 patients treated for hyperhidrosis and in 220 healthy volunteers. In all of the subjects the measurements were taken from four localizations (face, hands, armpits and trunk) and normalized by body surface of the participant. The measurements were taken twice for every participant to obtain test–retest correlations. Mean values and standard deviations (SD) have been evaluated and on that basis reference values were quantified. Thresholds for diagnosis of hyperhidrosis were quantified on the basis of normal distribution theory as healthy population mean +2 SD.

Results

In healthy volunteers, mean value of gravimetrically evaluated intensity of sweating were: facial: 19.15 ± 14.97 mg/min/m2, palmar: 18.49 ± 14.06 mg/min/m2, axillary: 42.39 ± 47.08 mg/min/m2 and plantar: 15.77 ± 16.87 mg/min/m2. Thresholds for diagnosis of hyperhidrosis were quantified, respectively as: 49, 46, 136 and 50 mg/min/m2. The overall test–retest correlation was 0.71.

Interpretation

Gravimetry is easy, reproducible and fast method of evaluation of sweating. The reference values are stable and can serve as a qualifying and follow-up tool for evaluation of the patients with PHH in any localization.
Literature
1.
2.
go back to reference Larson DL (2011) Definitive diagnosis and management of axillary hyperhidrosis: the VapoMeter and suction-assisted arthroscopic shaving. Aesthet Surg J 31(5):9–552CrossRef Larson DL (2011) Definitive diagnosis and management of axillary hyperhidrosis: the VapoMeter and suction-assisted arthroscopic shaving. Aesthet Surg J 31(5):9–552CrossRef
3.
go back to reference Heckmann M, Ceballos-Baumann AO, Plewig G (2001) Hyperhidrosis study group. botulinum toxin a for axillary hyperhidrosis (excessive sweating). N Engl J Med 344(7):93–488CrossRef Heckmann M, Ceballos-Baumann AO, Plewig G (2001) Hyperhidrosis study group. botulinum toxin a for axillary hyperhidrosis (excessive sweating). N Engl J Med 344(7):93–488CrossRef
4.
go back to reference Hund M, Kinkelin I, Naumann M, Hamm H (2002) Definition of axillary hyperhidrosis by gravimetric assessment. Arch Dermatol 138(4):41–539CrossRef Hund M, Kinkelin I, Naumann M, Hamm H (2002) Definition of axillary hyperhidrosis by gravimetric assessment. Arch Dermatol 138(4):41–539CrossRef
5.
go back to reference Stefaniak T, Proczko-Markuszewska M, Royton A, Idestal A et al. (2011) Importance of objective evaluation of sweating in qualification and follow-up of primary hyperhidrosis patients undergoing sympathectomy. In: International symposium on sympathetic surgery, Final program, Abs. p 5, Odense, Denmark, 17–19th June 2011 Stefaniak T, Proczko-Markuszewska M, Royton A, Idestal A et al. (2011) Importance of objective evaluation of sweating in qualification and follow-up of primary hyperhidrosis patients undergoing sympathectomy. In: International symposium on sympathetic surgery, Final program, Abs. p 5, Odense, Denmark, 17–19th June 2011
6.
go back to reference Stefaniak T, Pirski M, Osęka T, Kobiela J et al (2009) Simultaneous bilateral transthoracic sympathectomy through posterior access in Lin-Telaranta modification for primary hyperhidrosis. Videosurg miniinv 4(2):47–52 Stefaniak T, Pirski M, Osęka T, Kobiela J et al (2009) Simultaneous bilateral transthoracic sympathectomy through posterior access in Lin-Telaranta modification for primary hyperhidrosis. Videosurg miniinv 4(2):47–52
7.
go back to reference Verbraecken J, Van de Heyning P, De Backer W, Van Gaal L (2006) Body surface area in normal-weight, overweight, and obese adults. A comparison study. Metabolism 55(4):24–515CrossRef Verbraecken J, Van de Heyning P, De Backer W, Van Gaal L (2006) Body surface area in normal-weight, overweight, and obese adults. A comparison study. Metabolism 55(4):24–515CrossRef
8.
go back to reference Strutton DR, Kowalski JW, Glaser DA, Stang PE (2004) US prevalence of hyperhidrosis and impact on individuals with axillary hyperhidrosis: results from a national survey. J Am Acad Dermatol 51(2):8–241CrossRef Strutton DR, Kowalski JW, Glaser DA, Stang PE (2004) US prevalence of hyperhidrosis and impact on individuals with axillary hyperhidrosis: results from a national survey. J Am Acad Dermatol 51(2):8–241CrossRef
9.
go back to reference Kreyden OP, Heckmann M, Peschen M (2002) Delusional hyperhidrosis as a risk for medical overtreatment: a case of botulinophilia. Arch Dermatol 138(4):9–538CrossRef Kreyden OP, Heckmann M, Peschen M (2002) Delusional hyperhidrosis as a risk for medical overtreatment: a case of botulinophilia. Arch Dermatol 138(4):9–538CrossRef
10.
go back to reference Hong HC, Lupin M, O’Shaughnessy KF (2012) Clinical evaluation of a microwave device for treating axillary hyperhidrosis. Dermatol Surg 38(5):35–728 Hong HC, Lupin M, O’Shaughnessy KF (2012) Clinical evaluation of a microwave device for treating axillary hyperhidrosis. Dermatol Surg 38(5):35–728
11.
go back to reference Swaile DF, Elstun LT, Benzing KW (2012) Clinical studies of sweat rate reduction by an over-the-counter soft-solid antiperspirant and comparison with a prescription antiperspirant product in male panelists. Br J Dermatol 166(Suppl 1):6–22 Swaile DF, Elstun LT, Benzing KW (2012) Clinical studies of sweat rate reduction by an over-the-counter soft-solid antiperspirant and comparison with a prescription antiperspirant product in male panelists. Br J Dermatol 166(Suppl 1):6–22
12.
go back to reference Chia HY, Tan AS, Chong WS, Tey HL (2011) Efficacy of iontophoresis with glycopyrronium bromide for treatment of primary palmar hyperhidrosis. J Eur Acad Dermatol Venereol. 3 Aug 2011 [Epub ahead of print] Chia HY, Tan AS, Chong WS, Tey HL (2011) Efficacy of iontophoresis with glycopyrronium bromide for treatment of primary palmar hyperhidrosis. J Eur Acad Dermatol Venereol. 3 Aug 2011 [Epub ahead of print]
13.
go back to reference Absar MS, Onwudike M (2008) Efficacy of botulinum toxin type A in the treatment of focal axillary hyperhidrosis. Dermatol Surg 34(6):5–751CrossRef Absar MS, Onwudike M (2008) Efficacy of botulinum toxin type A in the treatment of focal axillary hyperhidrosis. Dermatol Surg 34(6):5–751CrossRef
14.
go back to reference Lowe NJ, Glaser DA, Eadie N, Daggett S et al (2007) North American botox in primary axillary hyperhidrosis clinical study group. botulinum toxin type A in the treatment of primary axillary hyperhidrosis: a 52-week multicenter double-blind, randomized, placebo-controlled study of efficacy and safety. J Am Acad Dermatol 56(4):11–604CrossRef Lowe NJ, Glaser DA, Eadie N, Daggett S et al (2007) North American botox in primary axillary hyperhidrosis clinical study group. botulinum toxin type A in the treatment of primary axillary hyperhidrosis: a 52-week multicenter double-blind, randomized, placebo-controlled study of efficacy and safety. J Am Acad Dermatol 56(4):11–604CrossRef
15.
go back to reference Lowe N, Campanati A, Bodokh I, Cliff S et al (2004) The place of botulinum toxin type A in the treatment of focal hyperhidrosis. Br J Dermatol 151(6):22–1115CrossRef Lowe N, Campanati A, Bodokh I, Cliff S et al (2004) The place of botulinum toxin type A in the treatment of focal hyperhidrosis. Br J Dermatol 151(6):22–1115CrossRef
16.
go back to reference Naumann M, Lowe NJ, Kumar CR, Hamm H (2003) Hyperhidrosis Clinical Investigators Group. Botulinum toxin type a is a safe and effective treatment for axillary hyperhidrosis over 16 months: a prospective study. Arch Dermatol 139(6):6–731CrossRef Naumann M, Lowe NJ, Kumar CR, Hamm H (2003) Hyperhidrosis Clinical Investigators Group. Botulinum toxin type a is a safe and effective treatment for axillary hyperhidrosis over 16 months: a prospective study. Arch Dermatol 139(6):6–731CrossRef
17.
go back to reference Goodman G (2003) Diffusion and short-term efficacy of botulinum toxin A after the addition of hyaluronidase and its possible application for the treatment of axillary hyperhidrosis. Dermatol Surg 29(5):8–533CrossRef Goodman G (2003) Diffusion and short-term efficacy of botulinum toxin A after the addition of hyaluronidase and its possible application for the treatment of axillary hyperhidrosis. Dermatol Surg 29(5):8–533CrossRef
18.
go back to reference Proebstle TM, Schneiders V, Knop J (2002) Gravimetrically controlled efficacy of subcorial curettage: a prospective study for treatment of axillary hyperhidrosis. Dermatol Surg 28(11):6–1022CrossRef Proebstle TM, Schneiders V, Knop J (2002) Gravimetrically controlled efficacy of subcorial curettage: a prospective study for treatment of axillary hyperhidrosis. Dermatol Surg 28(11):6–1022CrossRef
19.
go back to reference Lowe NJ, Yamauchi PS, Lask GP, Patnaik R et al (2002) Efficacy and safety of botulinum toxin type A in the treatment of palmar hyperhidrosis: a double-blind, randomized, placebo-controlled study. Dermatol Surg 28(9):7–822CrossRef Lowe NJ, Yamauchi PS, Lask GP, Patnaik R et al (2002) Efficacy and safety of botulinum toxin type A in the treatment of palmar hyperhidrosis: a double-blind, randomized, placebo-controlled study. Dermatol Surg 28(9):7–822CrossRef
Metadata
Title
Gravimetry in sweating assessment in primary hyperhidrosis and healthy individuals
Authors
Tomasz J. Stefaniak
Monika Proczko
Publication date
01-08-2013
Publisher
Springer Berlin Heidelberg
Published in
Clinical Autonomic Research / Issue 4/2013
Print ISSN: 0959-9851
Electronic ISSN: 1619-1560
DOI
https://doi.org/10.1007/s10286-013-0201-2

Other articles of this Issue 4/2013

Clinical Autonomic Research 4/2013 Go to the issue